Order Book Exceptional, Margins Pressured Near-Term—Hold for Deal Ramps

Coforge delivered a quarter that splits sharply between headline and substance. Revenue grew 50% YoY to ₹5,528 Crore and order book hit an all-time $2.23B—both strong. But profit growth (49% YoY) lagged revenue, and worse, profit fell 20% quarter-on-quarter despite revenue climbing 24% QoQ. The gap is ₹200 Crore in one-time and integration costs: ₹43 Crore in acquisition/exceptional items, ₹83 Crore in realized hedge losses, and ₹74 Crore in mark-to-market hedge impacts. Strip these out and normalized profit growth approaches 60%+ YoY—organic and clean. The question is whether margins recover as these costs wind down and large deals ramp.

Management flagged the timing clearly on the call. CFO Saurabh Goel noted: "Exceptional expenses and acquisition-related expenses recognized during the current quarter amounted to $6.5 million, compared with $5.4 million in Q4. We expect marginal integration costs in Q2 and none from Q3 onwards." The forex hedge position added $10 Crore of realized loss in Q1 and $14 Crore of mark-to-market loss (to crystallize Q2–Q3 as hedges unwind). Stripped of these, EBIT margin was clean 16.0% consolidated (Coforge standalone 16.7%), ahead of the 15.5% FY27 guidance. But the Q1 reported EBIT of 16.0% also benefited from just two months of Encora at a 19.1% EBIT rate—a honeymoon margin that may not hold for a full quarter.

The stock rallied +10.3% on day 1 of the result announcement (Jul 27) and held strength to a +14.3% gain by day 3. At ₹1,721 as of Jul 31, the stock sits 11.9% above its 20-day SMA (₹1,543), 16.2% above its 50-day SMA (₹1,480), and 13.5% below its all-time high (₹1,990). RSI at 70.8 signals overbought territory. Volume is increasing, suggesting interest, but institutional ownership tells a different story.

Foreign institutional investors trimmed 7.33 percentage points in Q1 FY27 (from 30.65% in Q4 to 23.32% now), and domestic institutions also pulled back 11.76pp (56.19% to 44.43%). This is institutional selling into the strength—a bearish signal. Smart money is often early on exits, and the magnitude of FII reduction suggests a deliberate trim rather than passive rebalancing. The narrative makes sense: Coforge delivered a strong order book and beat EBIT guidance, but large deals are unproven revenue (ramps 'mostly start Q3+'), organic growth is soft, and valuation at near-ATH offers limited margin of safety.

Coforge is not broken. Order book at all-time $2.23B, AI positioning strong, and Encora integration ahead of plan are all genuine wins. But Q1 profit growth (49% YoY) lagged revenue growth (50% YoY) and QoQ profit fell 20%, signaling that near-term margins are genuinely pressured. This is a 'Hold' rating—the bull case depends on large deals ramping on schedule and one-time costs normalizing by Q3–Q4. Management's track record is solid (21.7% revenue CAGR over 9 years), but organic growth this quarter was soft (1.1% CC sequential) and institutional investors are trimming positions at near-ATH valuations. Risk/reward at ₹1,721 is balanced-to-cautious.

The number to track from here: Standalone Coforge EBIT margin ex-Encora. Management's reaffirmed 16.5–17% guidance for FY27 is achievable if large deals ramp and one-time costs wind down, but the margin ceiling is 16.7% (where Coforge standalone landed in Q1). If that erodes below 16.5% as deals scale and costs persist, the 'exceptional' FY27 narrative cracks. Watch Q2 for clarity on whether integration costs truly recede and whether deal ramps offset any further organic softness.